RoseNose's dividend portfolio hits record high with 5.6% yield, flags overvalued stocks, and spots 5 undervalued buys.

MMR vaccine split faces years-long FDA hurdles; IBM partners with OpenAI for AI boost; Jack in the Box shows early recovery signs.

President Trump's executive order to separate the combined MMR vaccine into individual shots faces significant regulatory and manufacturing challenges, with FDA approval potentially taking up to 10 years. Merck and GSK, the only licensed producers of...